1. Targeting Gli transcription activation by small molecule suppresses tumor growth.
- Author
-
Bosco-Clément G, Zhang F, Chen Z, Zhou HM, Li H, Mikami I, Hirata T, Yagui-Beltran A, Lui N, Do HT, Cheng T, Tseng HH, Choi H, Fang LT, Kim IJ, Yue D, Wang C, Zheng Q, Fujii N, Mann M, Jablons DM, and He B
- Subjects
- Animals, Cell Line, Tumor, Cell Proliferation drug effects, Female, HCT116 Cells, HEK293 Cells, HT29 Cells, Hedgehog Proteins genetics, Hedgehog Proteins metabolism, Humans, Immunoblotting, Mice, Mice, Nude, NIH 3T3 Cells, Neoplasms genetics, Neoplasms pathology, Oligonucleotide Array Sequence Analysis, Protein Binding drug effects, Pyrazoles chemistry, Pyrazoles pharmacology, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Small Molecule Libraries chemistry, TATA-Binding Protein Associated Factors genetics, TATA-Binding Protein Associated Factors metabolism, Transcription Factor TFIID genetics, Transcription Factor TFIID metabolism, Transcription Factors metabolism, Transcriptome drug effects, Tumor Burden drug effects, Tumor Burden genetics, Xenograft Model Antitumor Assays, Zinc Finger Protein GLI1, Neoplasms prevention & control, Small Molecule Libraries pharmacology, Transcription Factors genetics, Transcriptional Activation drug effects
- Abstract
Targeted inhibition of Hedgehog signaling at the cell membrane has been associated with anticancer activity in preclinical and early clinical studies. Hedgehog signaling involves activation of Gli transcription factors that can also be induced by alternative pathways. In this study, we identified an interaction between Gli proteins and a transcription coactivator TBP-associated factor 9 (TAF9), and validated its functional relevance in regulating Gli transactivation. We also describe a novel, synthetic small molecule, FN1-8, that efficiently interferes with Gli/TAF9 interaction and downregulate Gli/TAF9-dependent transcriptional activity. More importantly, FN1-8 suppresses cancer cell proliferation in vitro and inhibits tumor growth in vivo. Our results suggest that blocking Gli transactivation, an important control point of multiple oncogenic pathways, may be an effective anticancer strategy.
- Published
- 2014
- Full Text
- View/download PDF